Gamma Knife Radiosurgery for Vestibular Schwannomas Tumor Control and Functional Preservation in 70 Patients

被引:18
作者
Arthurs, Benjamin J. [2 ,3 ]
Lamoreaux, Wayne T. [1 ,2 ]
Mackay, Alexander R. [2 ,4 ]
Demakas, John J. [2 ,5 ]
Giddings, Neil A. [2 ,6 ]
Fairbanks, Robert K. [1 ,2 ]
Cooke, Barton S. [2 ]
Elaimy, Ameer L. [2 ,7 ]
Peressini, Ben [8 ]
Lee, Christopher M. [1 ,2 ]
机构
[1] Canc Care NW, Spokane, WA 99202 USA
[2] Gamma Knife Spokane, Spokane, WA USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Mackay & Meyer MDs, Spokane, WA USA
[5] Spokane Brain & Spine, Spokane, WA USA
[6] Spokane Ear Nose & Throat Clin, Spokane, WA USA
[7] Carroll Coll, Helena, MT USA
[8] DataWorks NW LLC, Coeur Dalene, ID USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2011年 / 34卷 / 03期
关键词
vestibular schwannoma; acoustic neuroma; gamma knife; radiosurgery; radiation oncology; FRACTIONATED STEREOTACTIC RADIOTHERAPY; ACOUSTIC NEUROMAS; HEARING PRESERVATION; CONSERVATIVE MANAGEMENT; SINGLE-INSTITUTION; COMPLICATIONS; MICROSURGERY; METAANALYSIS; EXPERIENCE;
D O I
10.1097/COC.0b013e3181dbc2ab
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: We present the previously unreported outcomes of 70 patients treated with Gamma knife radiosurgery for vestibular schwannoma (VS), including comprehensive analysis of clinical outcomes and the effects of lower marginal doses. Methods: We performed a retrospective study of patients treated for VS at Gamma knife of Spokane between 2003 and 2008. Endpoints measured include tumor control, hearing preservation, and facial nerve preservation, including the effect of tumor size and marginal dose. Statistical analysis was performed with Wilcoxon signed-rank test, paired Student t test, Mann-Whitney U test, Kendall's rank correlation, Fisher exact test, and Liddell's exact chi(2) test for matched pairs. Results: With a mean follow-up of 26 months, 93.8% of tumors either shrank or remained static after receiving a mean marginal dose of 12.7 Gy. Tumor control was independent of marginal dose or tumor size. Hearing preservation was achieved in 64% of patients with serviceable function before the treatment. Hearing changes were independent of dose or tumor size. Preservation of good facial nerve function was achieved in 95% of patients. Post-treatment hydrocephalus occurred in 4.4% of patients, but no other significant morbidities were elucidated. Conclusions: In the treatment of VS, contemporary radiosurgical techniques and the use of marginal doses below 13 Gy offer excellent tumor control, at high rates relative to surgical intervention. These findings are independent of marginal dose and tumor size. Patients should be informed about the benefits and risks of radiosurgery and microsurgery before choosing an intervention. Further analysis of post-treatment outcomes should be encouraged as follow-up times increase and the treatment protocols continue to evolve.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 28 条
  • [1] TOWARD DOSE OPTIMIZATION FOR FRACTIONATED STEREOTACTIC RADIOTHERAPY FOR ACOUSTIC NEUROMAS: COMPARISON OF TWO DOSE COHORTS
    Andrews, David W.
    Werner-Wasik, Maria
    Den, Robert B.
    Paek, Sun Ha
    Downes-Phillips, Beverly
    Willcox, Thomas O.
    Bednarz, Greg
    Maltenfort, Mitchell
    Evans, James J.
    Curran, Walter J., Jr.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 419 - 426
  • [2] Comparison of growth patterns of acoustic neuromas with and without radiosurgery
    Battaglia, Alex
    Mastrodimos, Tbill
    Cueva, Roberto
    [J]. OTOLOGY & NEUROTOLOGY, 2006, 27 (05) : 705 - 712
  • [3] Stereotactic radiotherapy for vestibular schwannomas: Favorable outcome with minimal toxicity
    Chan, AW
    Black, PM
    Ojemann, RG
    Barker, FG
    Kooy, HM
    Lopes, VV
    McKenna, MJ
    Shrieve, DC
    Martuza, RL
    Loeffler, JS
    [J]. NEUROSURGERY, 2005, 57 (01) : 60 - 69
  • [4] Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): Long-term results in 106 patients treated in a single institution
    Combs, SE
    Volk, S
    Schulz-Ertner, D
    Huber, PE
    Thilmann, C
    Debus, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01): : 75 - 81
  • [5] Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy
    Flickinger, JC
    Kondziolka, D
    Niranjan, A
    Maitz, A
    Voynov, G
    Lunsford, LD
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : 225 - 230
  • [6] Evolution in technique for vestibular schwannoma radiosurgery and effect on outcome
    Flickinger, JC
    Kondziolka, D
    Pollock, BE
    Lunsford, LD
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (02): : 275 - 280
  • [7] HEARING PRESERVATION IN UNILATERAL ACOUSTIC NEUROMA SURGERY
    GARDNER, G
    ROBERTSON, JH
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1988, 97 (01) : 55 - 66
  • [8] FACIAL-NERVE GRADING SYSTEM
    HOUSE, JW
    BRACKMANN, DE
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1985, 93 (02) : 146 - 147
  • [9] A meta-analysis comparing outcomes of microsurgery and gamma knife radiosurgery
    Kaylie, DM
    Horgan, MJ
    Delashaw, JB
    McMenomey, S
    [J]. LARYNGOSCOPE, 2000, 110 (11) : 1850 - 1856
  • [10] Fractionated stereotactic radiotherapy for acoustic neuroma -: Single-institution experience at the Princess Margaret Hospital
    Koh, Eng-Siew
    Millar, Barbara-Ann
    Menard, Cynthia
    Michaels, Howard
    Heydarian, Mostafa
    Ladak, Shenaz
    McKinnon, Sharon
    Rutka, John A.
    Guha, Abhijit
    Pond, Gregory R.
    Laperriere, Normand J.
    [J]. CANCER, 2007, 109 (06) : 1203 - 1210